CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to significantly extend its half-life and enhance biological activity. Researchers study this peptide for its effects on growth hormone release, often in forms with or without DAC (Drug Affinity Complex).

In the literature, CJC-1295 appears most often in work focused on growth hormone, muscle growth and recovery. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.

Because it is catalogued here under powder peptides, CJC-1295 also shows up in discussions of anti-aging. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.